<table border="1"><tr><th>Systematic nomenclature (IUPAC nomenclature)</th><td><ul><li>3-(3-chloro-10,11-dihydro-5 | H | -dibenzo[ | b |, | f | ]azepin-5-yl)- | N |, | N | -dimethylpropan-1-amine</li></ul></td></tr><tr><th>Identification</th><td><ul><li>CAS Registry | 303-49-1 | ATC Code | N06 | AA04 | PubChem | 2801 | Drumbank | DB01242 | ChemSpider | 2699.</li></ul></td></tr><tr><th>Chemical properties.</th><td><ul><li>Chemical | C | 19 | H | 23 | Cl | N | 2 | Molecular mass | 314.857 g/mol | Euclidean | Clomimipramine; 3-Chloroimipramine; G-34586</li></ul></td></tr><tr><th>Pharmaceutical Information</th><td><ul><li>Biocompatibility | ~50% | Protein Compatibility | 96–98% | Drug Interaction | liver (CYP2D6) | Biological Reactivity | CMI | : 19–37 hours | DCMI | : 54–77 hours | Outflow | Kidney (51–60%) | feces (24–32%)</li></ul></td></tr><tr><th>Prescription Recommendations</th><td><ul><li>Authorization Information | FDA | Home Page | Pregnant Safety | C | (Australia) | C | (United States) | Legal Status | Prescription Requirement (S4) | (Australia) |  | -only | (Canada) | POM | (United Kingdom) |  | -only | (United States) | How to Inject | By mouth, intravenous</li></ul></td></tr></table>